Compare top Follicular lymphoma doctors and prices in Israel. Find your best match here.
We'll hand-pick the best doctors based on your needs and budget.
Meet the experts behind this page
Medically reviewed by Fahad Mawlood
Medical Editor & Data ScientistTop doctors
1
Israel
Reviews
14,000+
From real patients
Get free personalized treatment plans and choose the best option. No commitment · No payments for our services
Recognized by Forbes as one of the best doctors in 2018 – Dr. Stepensky has performed over 3,500 bone marrow transplants.
Choosing a clinic abroad can be stressful. At Bookimed, with over 800K patients helped, we understand your concerns. We know how to find trusted doctors, the best price-quality options, and solutions for even complex cases. We’re here to guide you every step of the way.
Yan Matsiivskiy
Head of Medical Coordinator Team
4300++ patient journeys guided
3 years at Bookimed
142 patients from Israel have found their doctor through us this month
2 min Quiz
Tell us your goal, budget, timeline
Human Matching + AI
Our algorithm finds matches, coordinator verifies fit
Your Options Ready
Compare prices, packages, dates. Chat with your coordinator
Overwhelmed by choices?
Guiding your treatment
Medically trained personal coordinators
| Rank | Doctor | experience | Good Fit For | What Sets Them Apart | Clinic & Location | Consultation |
|---|---|---|---|---|---|---|
| #1 | 28 years of experience | Pediatric blood cancers | Forbes-recognized expert with 3,500+ bone marrow transplants. Special focus on rare pediatric blood disorders at Hadassah Medical Center. | Israel | Price on request
|
Top-rated follicular lymphoma specialists in Israel include Dr. Ilia Kirshner, Dr. Polina Stepensky, and Dr. Ron Ram. These experts hold fellowships from major U.S. institutions like Montefiore Medical Center and focus on advanced therapies, such as bone marrow transplants and clinical trials for resistant cases.
Bookimed Expert Insight: While many doctors treat blood cancers, top Israeli specialists like Dr. Ilia Kirshner and Dr. Ofer Spielberg focus specifically on resistant follicular lymphoma. Patients often benefit from their involvement in phase III clinical trials, providing access to therapies not yet widely available in other countries.
Patient Consensus: Individuals treated for lymphoma suggest seeking second opinions when a watch-and-wait approach is suggested. They prefer major academic hospitals over smaller clinics because these centers offer clearer explanations of complex treatment paths.
Leading follicular lymphoma specialists are located in Tel Aviv and Ramat Gan at major JCI-accredited hospitals. Key experts include Dr. Avigdor Avraham at Sheba Medical Center and Dr. Fredi Aviv at Sourasky Medical Center, who specialize in lymphoid malignancies and bone marrow transplantation.
Bookimed Expert Insight: Top Israeli hematologists often have double fellowships in hematology and oncology. For example, Dr. Ilia Kirshner and Dr. Hila Magen trained at major U.S. institutions like Montefiore and MD Anderson. These specialists typically lead clinical trials, providing patients with access to newer therapies for resistant follicular lymphoma.
Patient Consensus: Many patients find it helpful to seek hematologists who trained at top American cancer centers. They emphasize choosing specialists who focus solely on lymphoma rather than treating many general cancers. Those treated in Israel noted that leading teams integrate CAR T-cell therapy alongside traditional bone marrow transplants.
International patients can have remote consultations with follicular lymphoma specialists in Israel before traveling. Many senior oncohematologists at centers like Sheba and Sourasky use video calls to review pathology and plan treatment. These virtual meetings help confirm diagnoses and discuss advanced options like CAR-T cell therapy.
Bookimed Expert Insight: While many doctors offer remote visits, choosing a specialist at a university-affiliated hospital is beneficial. Specialists like Dr. Fredi Aviv have 30+ years of experience within these academic systems. This ensures your remote evaluation is backed by the latest clinical research and multidisciplinary lab support.
Patient Consensus: Patients recommend preparing digital copies of all pathology slides and imaging before the call. Those who had remote meetings felt more prepared for their physical trip to Israel. It helped them clarify the next steps with their clinical team before leaving home.
Overseas patients do not need a formal doctor referral to schedule a follicular lymphoma specialist. Instead, Israeli centers require your full medical history and pathology reports for initial review. This ensures the hematologist can confirm your diagnosis and treatment plan before you travel to Tel Aviv.
Bookimed Expert Insight: While a physical referral is not mandatory, selecting a doctor with training in specific modern therapies is vital. For example, Dr. Ilia Kirshner at Sourasky focuses on clinical trials for treatment-resistant cases. This allows patients who have not responded to standard care to access next-generation therapies during their visit.
Patient Consensus: Patients were often surprised by how quickly they could connect with Israeli specialists after sharing their files. Many felt relieved after seeing a doctor who reviewed their records in advance and explained the next steps clearly.
When meeting with a follicular lymphoma specialist in Israel, ask about your specific pathology and tumor burden. Prepare questions regarding the necessity of immediate treatment versus active surveillance. Inquire about advanced options like CAR-T cell therapy or clinical trials available at centers like Sheba Medical Center.
Bookimed Expert Insight: Patients should verify if their specialist has experience with PET/CT-based prognostics or CAR-T cell therapy. For example, Dr. Abraham Avigdor at Sheba Medical Center has published 130+ studies on these advanced methods. Since follicular lymphoma is often managed over decades, choosing a doctor with access to both standard chemotherapy and next-generation cellular therapies is vital for long-term planning.
Patient Consensus: Patients often feel relieved when specialists explain which symptoms truly matter, such as specific changes that signal progression. Many recommend bringing all previous scan reports to the first visit to keep the conversation focused on the immediate next steps.